PharmaVoice 8 janv. 2026 Billionaire Sean Parker has already shaken up cancer R&D. Can his nonprofit fix the funding gap?
PharmaVoice 19 déc. 2025 Biogen’s CIO is betting on a tech and AI overhaul to ‘pave the highways’ toward growth
PharmaVoice 16 déc. 2025 5 CDER directors in one year? Turnover threatens ‘institutional memory’ at US health agencies.
PharmaVoice 10 déc. 2025 Another genetic testing company? Why a different approach could boost drug predictions and R&D.